Parallax Volatility Advisers, L.P. - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 132 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.

Quarter-by-quarter ownership
Parallax Volatility Advisers, L.P. ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$291,000
-91.9%
8,442
-92.2%
0.00%
-100.0%
Q4 2019$3,600,000
+252.9%
107,551
+119.5%
0.00%
+300.0%
Q2 2019$1,020,000
-6.8%
49,0000.0%0.00%0.0%
Q1 2019$1,095,000
+14.2%
49,000
+22.1%
0.00%0.0%
Q4 2018$959,000
-56.1%
40,141
-49.8%
0.00%
-66.7%
Q3 2018$2,184,000
+68.9%
80,000
+66.4%
0.00%
+50.0%
Q2 2018$1,293,000
+2294.4%
48,072
+2727.8%
0.00%
Q1 2018$54,000
-73.3%
1,700
-68.1%
0.00%
Q4 2017$202,0005,3340.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 414,500$14,280,00013.67%
Burrage Capital Management LLC 332,546$11,456,0009.04%
Penn Mutual Asset Management, LLC 158,783$5,470,0007.72%
First Trust Capital Management L.P. 525,598$18,107,0004.87%
GARDNER LEWIS ASSET MANAGEMENT L P 653,711$22,520,0004.08%
ALPINE ASSOCIATES MANAGEMENT INC. 2,075,100$71,488,0003.76%
S. MUOIO & CO. LLC 90,000$3,101,0003.52%
EQUITEC PROPRIETARY MARKETS, LLC 124,700$4,296,0003.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 501,719$17,284,0003.11%
WATER ISLAND CAPITAL LLC 1,062,245$36,594,0003.11%
View complete list of AIMMUNE THERAPEUTICS INC shareholders